CeleCor Therapeutics

Del Mar, United States

CeleCor Therapeutics develops first-point contact treatments for segment elevated myocardial infarction.

$45.5M raised

Mar 2022

Venture - Series Unknown

Biotechnology Medical Therapeutics

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CeleCor Therapeutics

How much funding has CeleCor Therapeutics raised?

CeleCor Therapeutics has raised $45.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2022.

Where is CeleCor Therapeutics headquartered?

CeleCor Therapeutics is headquartered in Del Mar, United States.

What does CeleCor Therapeutics do?

CeleCor Therapeutics develops first-point contact treatments for segment elevated myocardial infarction.

What stage is CeleCor Therapeutics at?

CeleCor Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 8, 2022.

MLA

"CeleCor Therapeutics — Funding & Investors." VCBacked, March 8, 2022, https://www.vcbacked.co/company/celecor-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). CeleCor Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/celecor-therapeutics

Wikipedia (cite web)

{{cite web |title=CeleCor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celecor-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 8, 2022.